nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS1—ulcerative colitis	0.21	0.481	CbGaD
Bismuth Subsalicylate—PTGS2—ulcerative colitis	0.12	0.275	CbGaD
Bismuth Subsalicylate—ALB—ulcerative colitis	0.107	0.245	CbGaD
Bismuth Subsalicylate—PTGS2—Olsalazine—ulcerative colitis	0.0688	0.15	CbGbCtD
Bismuth Subsalicylate—PTGS2—Balsalazide—ulcerative colitis	0.0613	0.134	CbGbCtD
Bismuth Subsalicylate—PTGS1—Olsalazine—ulcerative colitis	0.0581	0.127	CbGbCtD
Bismuth Subsalicylate—PTGS1—Balsalazide—ulcerative colitis	0.0518	0.113	CbGbCtD
Bismuth Subsalicylate—PTGS2—Mesalazine—ulcerative colitis	0.049	0.107	CbGbCtD
Bismuth Subsalicylate—PTGS1—Mesalazine—ulcerative colitis	0.0414	0.0901	CbGbCtD
Bismuth Subsalicylate—PTGS2—Sulfasalazine—ulcerative colitis	0.0274	0.0596	CbGbCtD
Bismuth Subsalicylate—PTGS2—Triamcinolone—ulcerative colitis	0.0274	0.0596	CbGbCtD
Bismuth Subsalicylate—PTGS2—Betamethasone—ulcerative colitis	0.0235	0.0512	CbGbCtD
Bismuth Subsalicylate—PTGS1—Sulfasalazine—ulcerative colitis	0.0231	0.0504	CbGbCtD
Bismuth Subsalicylate—ALB—Prednisone—ulcerative colitis	0.0138	0.0301	CbGbCtD
Bismuth Subsalicylate—PTGS2—Dexamethasone—ulcerative colitis	0.0137	0.0298	CbGbCtD
Bismuth Subsalicylate—TF—bile—ulcerative colitis	0.013	0.565	CbGeAlD
Bismuth Subsalicylate—TF—epithelium—ulcerative colitis	0.00186	0.0812	CbGeAlD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.00151	0.0556	CbGpPWpGaD
Bismuth Subsalicylate—TF—lymphoid tissue—ulcerative colitis	0.00143	0.0625	CbGeAlD
Bismuth Subsalicylate—TF—digestive system—ulcerative colitis	0.00142	0.0618	CbGeAlD
Bismuth Subsalicylate—TF—Differentiation Pathway—CXCR1—ulcerative colitis	0.00141	0.0519	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.0012	0.0441	CbGpPWpGaD
Bismuth Subsalicylate—TF—liver—ulcerative colitis	0.00105	0.046	CbGeAlD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000784	0.0288	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000728	0.0267	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000606	0.247	CbGdCrCtD
Bismuth Subsalicylate—PTGS1—epithelium—ulcerative colitis	0.000552	0.0241	CbGeAlD
Bismuth Subsalicylate—ALB—liver—ulcerative colitis	0.000549	0.0239	CbGeAlD
Bismuth Subsalicylate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000544	0.02	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—CALM3—ulcerative colitis	0.000539	0.0198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—smooth muscle tissue—ulcerative colitis	0.000532	0.0232	CbGeAlD
Bismuth Subsalicylate—PTGS2—epithelium—ulcerative colitis	0.000527	0.023	CbGeAlD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	0.000514	0.0189	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—smooth muscle tissue—ulcerative colitis	0.000508	0.0222	CbGeAlD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000494	0.0181	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—ABCB1—ulcerative colitis	0.000489	0.018	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—RUNX3—ulcerative colitis	0.000483	0.0178	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—PROCR—ulcerative colitis	0.000454	0.0167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.00043	0.0158	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000426	0.0157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—digestive system—ulcerative colitis	0.00042	0.0183	CbGeAlD
Bismuth Subsalicylate—PTGS2—lymphoid tissue—ulcerative colitis	0.000406	0.0177	CbGeAlD
Bismuth Subsalicylate—Stinging—Hydrocortisone—ulcerative colitis	0.000402	0.00778	CcSEcCtD
Bismuth Subsalicylate—PTGS2—digestive system—ulcerative colitis	0.000401	0.0175	CbGeAlD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000393	0.0144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000378	0.0139	CbGpPWpGaD
Bismuth Subsalicylate—Stinging—Triamcinolone—ulcerative colitis	0.000378	0.00732	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Budesonide—ulcerative colitis	0.000373	0.00722	CcSEcCtD
Bismuth Subsalicylate—Deafness—Mesalazine—ulcerative colitis	0.000371	0.00719	CcSEcCtD
Bismuth Subsalicylate—Erythema—Nicotine—ulcerative colitis	0.000357	0.00692	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000353	0.013	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Nicotine—ulcerative colitis	0.00035	0.00677	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	0.000344	0.0126	CbGpPWpGaD
Bismuth Subsalicylate—Stinging—Betamethasone—ulcerative colitis	0.000343	0.00664	CcSEcCtD
Bismuth Subsalicylate—Stinging—Dexamethasone—ulcerative colitis	0.000343	0.00664	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Mesalazine—ulcerative colitis	0.000339	0.00656	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Budesonide—ulcerative colitis	0.000321	0.00622	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Dexamethasone—ulcerative colitis	0.000319	0.00617	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Betamethasone—ulcerative colitis	0.000319	0.00617	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Hydrocortisone—ulcerative colitis	0.000311	0.00602	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000307	0.0113	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal pain upper—Mesalazine—ulcerative colitis	0.000303	0.00587	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Azathioprine—ulcerative colitis	0.000302	0.00585	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisolone—ulcerative colitis	0.000301	0.00583	CcSEcCtD
Bismuth Subsalicylate—Oedema—Mercaptopurine—ulcerative colitis	0.000301	0.00582	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.0003	0.011	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—liver—ulcerative colitis	0.000299	0.013	CbGeAlD
Bismuth Subsalicylate—Oesophagitis—Hydrocortisone—ulcerative colitis	0.000297	0.00576	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Budesonide—ulcerative colitis	0.000297	0.00575	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	0.000296	0.0109	CbGpPWpGaD
Bismuth Subsalicylate—Ecchymosis—Hydrocortisone—ulcerative colitis	0.000294	0.0057	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Nicotine—ulcerative colitis	0.000294	0.00569	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000293	0.119	CbGdCrCtD
Bismuth Subsalicylate—Skin exfoliation—Triamcinolone—ulcerative colitis	0.000293	0.00566	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methylprednisolone—ulcerative colitis	0.000292	0.00565	CcSEcCtD
Bismuth Subsalicylate—Oedema—Nicotine—ulcerative colitis	0.000291	0.00564	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000288	0.118	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000288	0.118	CbGdCrCtD
Bismuth Subsalicylate—Asthma—Mesalazine—ulcerative colitis	0.000287	0.00556	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Mercaptopurine—ulcerative colitis	0.000287	0.00555	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000283	0.0104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000281	0.115	CbGdCrCtD
Bismuth Subsalicylate—Oesophagitis—Methylprednisolone—ulcerative colitis	0.000279	0.00541	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Triamcinolone—ulcerative colitis	0.000277	0.00536	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Methylprednisolone—ulcerative colitis	0.000276	0.00535	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Mesalazine—ulcerative colitis	0.000275	0.00533	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	0.000274	0.01	CbGpPWpGaD
Bismuth Subsalicylate—Skin exfoliation—Betamethasone—ulcerative colitis	0.000265	0.00514	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Dexamethasone—ulcerative colitis	0.000265	0.00514	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000263	0.00965	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—ALB—ulcerative colitis	0.000262	0.00964	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Mercaptopurine—ulcerative colitis	0.000261	0.00506	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Mesalazine—ulcerative colitis	0.000261	0.00506	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Nicotine—ulcerative colitis	0.000259	0.00502	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Nicotine—ulcerative colitis	0.000257	0.00497	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Betamethasone—ulcerative colitis	0.000254	0.00492	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Dexamethasone—ulcerative colitis	0.000254	0.00492	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Dexamethasone—ulcerative colitis	0.000251	0.00487	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Betamethasone—ulcerative colitis	0.000251	0.00487	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ALB—ulcerative colitis	0.00025	0.00918	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—ulcerative colitis	0.00025	0.00918	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Nicotine—ulcerative colitis	0.000249	0.00483	CcSEcCtD
Bismuth Subsalicylate—Pain—Nicotine—ulcerative colitis	0.000249	0.00483	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000244	0.00895	CbGpPWpGaD
Bismuth Subsalicylate—Epistaxis—Mesalazine—ulcerative colitis	0.000241	0.00468	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Hydrocortisone—ulcerative colitis	0.000241	0.00467	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Budesonide—ulcerative colitis	0.000241	0.00466	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Nicotine—ulcerative colitis	0.00024	0.00465	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	0.000239	0.00879	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.000239	0.00877	CbGpPWpGaD
Bismuth Subsalicylate—Erythema multiforme—Azathioprine—ulcerative colitis	0.000239	0.00462	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000238	0.0046	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000232	0.00851	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000232	0.00851	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Nicotine—ulcerative colitis	0.000232	0.00448	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Prednisone—ulcerative colitis	0.000231	0.00448	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Nicotine—ulcerative colitis	0.00023	0.00446	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Mesalazine—ulcerative colitis	0.00023	0.00445	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Prednisone—ulcerative colitis	0.000221	0.00428	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisone—ulcerative colitis	0.000219	0.00424	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Mesalazine—ulcerative colitis	0.000217	0.00421	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Hydrocortisone—ulcerative colitis	0.000216	0.00418	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Mesalazine—ulcerative colitis	0.000214	0.00415	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Nicotine—ulcerative colitis	0.000206	0.00399	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Betamethasone—ulcerative colitis	0.000206	0.00399	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Dexamethasone—ulcerative colitis	0.000206	0.00399	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000206	0.00399	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	0.000206	0.00756	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Budesonide—ulcerative colitis	0.000202	0.00392	CcSEcCtD
Bismuth Subsalicylate—Erythema—Mesalazine—ulcerative colitis	0.0002	0.00387	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000199	0.00733	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Nicotine—ulcerative colitis	0.000199	0.00386	CcSEcCtD
Bismuth Subsalicylate—Infection—Budesonide—ulcerative colitis	0.000199	0.00386	CcSEcCtD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—ulcerative colitis	0.000198	0.00726	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000196	0.00722	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Mesalazine—ulcerative colitis	0.000196	0.00379	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Nicotine—ulcerative colitis	0.000193	0.00373	CcSEcCtD
Bismuth Subsalicylate—Asthma—Triamcinolone—ulcerative colitis	0.000192	0.00372	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Budesonide—ulcerative colitis	0.000191	0.00371	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mercaptopurine—ulcerative colitis	0.000191	0.0037	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Prednisolone—ulcerative colitis	0.00019	0.00368	CcSEcCtD
Bismuth Subsalicylate—Rash—Mercaptopurine—ulcerative colitis	0.00019	0.00367	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mercaptopurine—ulcerative colitis	0.000189	0.00367	CcSEcCtD
Bismuth Subsalicylate—TF—Differentiation Pathway—IL6—ulcerative colitis	0.000188	0.00691	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Hydrocortisone—ulcerative colitis	0.000186	0.0036	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Nicotine—ulcerative colitis	0.000185	0.00359	CcSEcCtD
Bismuth Subsalicylate—Rash—Nicotine—ulcerative colitis	0.000184	0.00356	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Nicotine—ulcerative colitis	0.000184	0.00356	CcSEcCtD
Bismuth Subsalicylate—Headache—Nicotine—ulcerative colitis	0.000183	0.00354	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Prednisone—ulcerative colitis	0.000179	0.00347	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mercaptopurine—ulcerative colitis	0.000179	0.00346	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Budesonide—ulcerative colitis	0.000178	0.00346	CcSEcCtD
Bismuth Subsalicylate—Infection—Azathioprine—ulcerative colitis	0.000178	0.00345	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—GNA12—ulcerative colitis	0.000177	0.00651	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	0.000177	0.0065	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Budesonide—ulcerative colitis	0.000177	0.00342	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000177	0.0721	CbGdCrCtD
Bismuth Subsalicylate—Weight increased—Triamcinolone—ulcerative colitis	0.000175	0.00339	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Methylprednisolone—ulcerative colitis	0.000175	0.00338	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Budesonide—ulcerative colitis	0.000175	0.00338	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—ITGAL—ulcerative colitis	0.000174	0.00639	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000174	0.0709	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000174	0.0709	CbGdCrCtD
Bismuth Subsalicylate—Nausea—Nicotine—ulcerative colitis	0.000173	0.00335	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	0.000172	0.00631	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Budesonide—ulcerative colitis	0.000172	0.00332	CcSEcCtD
Bismuth Subsalicylate—Constipation—Budesonide—ulcerative colitis	0.000172	0.00332	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000171	0.00629	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	0.000171	0.00627	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—MPO—ulcerative colitis	0.00017	0.00625	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.00017	0.0693	CbGdCrCtD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—ulcerative colitis	0.000166	0.0061	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	0.000166	0.00609	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Budesonide—ulcerative colitis	0.000165	0.0032	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Mesalazine—ulcerative colitis	0.000165	0.00319	CcSEcCtD
Bismuth Subsalicylate—Oedema—Mesalazine—ulcerative colitis	0.000163	0.00316	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.000163	0.00597	CbGpPWpGaD
Bismuth Subsalicylate—Hallucination—Hydrocortisone—ulcerative colitis	0.000163	0.00315	CcSEcCtD
Bismuth Subsalicylate—Infection—Mesalazine—ulcerative colitis	0.000162	0.00314	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Triamcinolone—ulcerative colitis	0.000162	0.00313	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Budesonide—ulcerative colitis	0.000159	0.00309	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Dexamethasone—ulcerative colitis	0.000159	0.00307	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Betamethasone—ulcerative colitis	0.000159	0.00307	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Budesonide—ulcerative colitis	0.000159	0.00307	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000158	0.00582	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	0.000158	0.00581	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Mesalazine—ulcerative colitis	0.000156	0.00301	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Methylprednisolone—ulcerative colitis	0.000153	0.00296	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Azathioprine—ulcerative colitis	0.000148	0.00286	CcSEcCtD
Bismuth Subsalicylate—Erythema—Prednisolone—ulcerative colitis	0.000146	0.00282	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Mesalazine—ulcerative colitis	0.000145	0.00281	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000144	0.0053	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Mesalazine—ulcerative colitis	0.000144	0.00278	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000144	0.00528	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000143	0.00524	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Hydrocortisone—ulcerative colitis	0.000142	0.00275	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Budesonide—ulcerative colitis	0.000142	0.00275	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Mesalazine—ulcerative colitis	0.000142	0.00275	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Azathioprine—ulcerative colitis	0.000142	0.00274	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	0.000141	0.00518	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000141	0.00518	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Mesalazine—ulcerative colitis	0.00014	0.0027	CcSEcCtD
Bismuth Subsalicylate—Pain—Mesalazine—ulcerative colitis	0.00014	0.0027	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Dexamethasone—ulcerative colitis	0.000139	0.00269	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Betamethasone—ulcerative colitis	0.000139	0.00269	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	0.000139	0.0051	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—MPO—ulcerative colitis	0.000138	0.00508	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Prednisone—ulcerative colitis	0.000138	0.00268	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Budesonide—ulcerative colitis	0.000137	0.00266	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000136	0.00499	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Mesalazine—ulcerative colitis	0.000135	0.00261	CcSEcCtD
Bismuth Subsalicylate—Erythema—Triamcinolone—ulcerative colitis	0.000134	0.00259	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methylprednisolone—ulcerative colitis	0.000134	0.00259	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Budesonide—ulcerative colitis	0.000133	0.00257	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Triamcinolone—ulcerative colitis	0.000131	0.00254	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.000131	0.00479	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Mesalazine—ulcerative colitis	0.00013	0.00251	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mesalazine—ulcerative colitis	0.000129	0.0025	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Budesonide—ulcerative colitis	0.000128	0.00247	CcSEcCtD
Bismuth Subsalicylate—Rash—Budesonide—ulcerative colitis	0.000127	0.00245	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Budesonide—ulcerative colitis	0.000126	0.00245	CcSEcCtD
Bismuth Subsalicylate—Headache—Budesonide—ulcerative colitis	0.000126	0.00244	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.000125	0.0046	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000125	0.00459	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—CALM3—ulcerative colitis	0.000123	0.00453	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Azathioprine—ulcerative colitis	0.000123	0.00237	CcSEcCtD
Bismuth Subsalicylate—Erythema—Dexamethasone—ulcerative colitis	0.000122	0.00235	CcSEcCtD
Bismuth Subsalicylate—Erythema—Betamethasone—ulcerative colitis	0.000122	0.00235	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	0.000121	0.00446	CbGpPWpGaD
Bismuth Subsalicylate—Hallucination—Prednisone—ulcerative colitis	0.000121	0.00234	CcSEcCtD
Bismuth Subsalicylate—Nausea—Budesonide—ulcerative colitis	0.000119	0.00231	CcSEcCtD
Bismuth Subsalicylate—Oedema—Prednisolone—ulcerative colitis	0.000119	0.0023	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Azathioprine—ulcerative colitis	0.000119	0.0023	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000117	0.00429	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	0.000116	0.00428	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Hydrocortisone—ulcerative colitis	0.000116	0.00225	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Mesalazine—ulcerative colitis	0.000116	0.00224	CcSEcCtD
Bismuth Subsalicylate—Infection—Hydrocortisone—ulcerative colitis	0.000115	0.00223	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Azathioprine—ulcerative colitis	0.000114	0.00221	CcSEcCtD
Bismuth Subsalicylate—Rash—Azathioprine—ulcerative colitis	0.000113	0.00219	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Azathioprine—ulcerative colitis	0.000113	0.00219	CcSEcCtD
Bismuth Subsalicylate—Headache—Azathioprine—ulcerative colitis	0.000112	0.00217	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	0.000112	0.00412	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Mesalazine—ulcerative colitis	0.000112	0.00216	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Hydrocortisone—ulcerative colitis	0.000111	0.00214	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	0.00011	0.00405	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Methylprednisolone—ulcerative colitis	0.00011	0.00213	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—MPO—ulcerative colitis	0.00011	0.00404	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Triamcinolone—ulcerative colitis	0.000109	0.00212	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	0.000109	0.004	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Triamcinolone—ulcerative colitis	0.000109	0.0021	CcSEcCtD
Bismuth Subsalicylate—Infection—Methylprednisolone—ulcerative colitis	0.000108	0.0021	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000108	0.00398	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Mesalazine—ulcerative colitis	0.000108	0.00209	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	0.000108	0.00396	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Azathioprine—ulcerative colitis	0.000106	0.00206	CcSEcCtD
Bismuth Subsalicylate—Erythema—Prednisone—ulcerative colitis	0.000106	0.00205	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mesalazine—ulcerative colitis	0.000104	0.00201	CcSEcCtD
Bismuth Subsalicylate—Rash—Mesalazine—ulcerative colitis	0.000103	0.00199	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mesalazine—ulcerative colitis	0.000103	0.00199	CcSEcCtD
Bismuth Subsalicylate—Headache—Mesalazine—ulcerative colitis	0.000102	0.00198	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000102	0.00198	CcSEcCtD
Bismuth Subsalicylate—Pain—Prednisolone—ulcerative colitis	0.000102	0.00197	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000101	0.00372	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000101	0.00195	CcSEcCtD
Bismuth Subsalicylate—Pain—Hydrocortisone—ulcerative colitis	9.93e-05	0.00192	CcSEcCtD
Bismuth Subsalicylate—Oedema—Dexamethasone—ulcerative colitis	9.92e-05	0.00192	CcSEcCtD
Bismuth Subsalicylate—Oedema—Betamethasone—ulcerative colitis	9.92e-05	0.00192	CcSEcCtD
Bismuth Subsalicylate—Infection—Dexamethasone—ulcerative colitis	9.85e-05	0.00191	CcSEcCtD
Bismuth Subsalicylate—Infection—Betamethasone—ulcerative colitis	9.85e-05	0.00191	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—CALM3—ulcerative colitis	9.83e-05	0.00361	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Prednisolone—ulcerative colitis	9.8e-05	0.0019	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mesalazine—ulcerative colitis	9.7e-05	0.00188	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Triamcinolone—ulcerative colitis	9.62e-05	0.00186	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methylprednisolone—ulcerative colitis	9.6e-05	0.00186	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	9.57e-05	0.00352	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Hydrocortisone—ulcerative colitis	9.57e-05	0.00185	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	9.49e-05	0.00348	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Dexamethasone—ulcerative colitis	9.45e-05	0.00183	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Betamethasone—ulcerative colitis	9.45e-05	0.00183	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Prednisolone—ulcerative colitis	9.44e-05	0.00183	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	9.44e-05	0.00347	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	9.36e-05	0.00344	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Triamcinolone—ulcerative colitis	9.35e-05	0.00181	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Hydrocortisone—ulcerative colitis	9.22e-05	0.00179	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Hydrocortisone—ulcerative colitis	9.18e-05	0.00178	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TNF—ulcerative colitis	9.08e-05	0.00334	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Triamcinolone—ulcerative colitis	9.01e-05	0.00174	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	9e-05	0.00331	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Methylprednisolone—ulcerative colitis	8.99e-05	0.00174	CcSEcCtD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	8.94e-05	0.00329	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	8.9e-05	0.00327	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Dexamethasone—ulcerative colitis	8.73e-05	0.00169	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Betamethasone—ulcerative colitis	8.73e-05	0.00169	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Triamcinolone—ulcerative colitis	8.68e-05	0.00168	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methylprednisolone—ulcerative colitis	8.66e-05	0.00168	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Triamcinolone—ulcerative colitis	8.64e-05	0.00167	CcSEcCtD
Bismuth Subsalicylate—Oedema—Prednisone—ulcerative colitis	8.64e-05	0.00167	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Dexamethasone—ulcerative colitis	8.62e-05	0.00167	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Betamethasone—ulcerative colitis	8.62e-05	0.00167	CcSEcCtD
Bismuth Subsalicylate—Infection—Prednisone—ulcerative colitis	8.58e-05	0.00166	CcSEcCtD
Bismuth Subsalicylate—Pain—Dexamethasone—ulcerative colitis	8.48e-05	0.00164	CcSEcCtD
Bismuth Subsalicylate—Pain—Betamethasone—ulcerative colitis	8.48e-05	0.00164	CcSEcCtD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	8.3e-05	0.00305	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	8.3e-05	0.00305	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.3e-05	0.00305	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	8.28e-05	0.00304	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	8.27e-05	0.00304	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PROCR—ulcerative colitis	8.27e-05	0.00304	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Prednisone—ulcerative colitis	8.23e-05	0.00159	CcSEcCtD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	8.22e-05	0.00302	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Hydrocortisone—ulcerative colitis	8.21e-05	0.00159	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Betamethasone—ulcerative colitis	8.17e-05	0.00158	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Dexamethasone—ulcerative colitis	8.17e-05	0.00158	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Hydrocortisone—ulcerative colitis	7.94e-05	0.00154	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—MMP1—ulcerative colitis	7.92e-05	0.00291	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Betamethasone—ulcerative colitis	7.88e-05	0.00153	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Dexamethasone—ulcerative colitis	7.88e-05	0.00153	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Prednisolone—ulcerative colitis	7.86e-05	0.00152	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	7.85e-05	0.00289	CbGpPWpGaD
Bismuth Subsalicylate—Body temperature increased—Betamethasone—ulcerative colitis	7.84e-05	0.00152	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Dexamethasone—ulcerative colitis	7.84e-05	0.00152	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	7.75e-05	0.00285	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Triamcinolone—ulcerative colitis	7.73e-05	0.0015	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methylprednisolone—ulcerative colitis	7.72e-05	0.00149	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Hydrocortisone—ulcerative colitis	7.68e-05	0.00149	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Prednisone—ulcerative colitis	7.6e-05	0.00147	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	7.55e-05	0.00277	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Prednisone—ulcerative colitis	7.51e-05	0.00145	CcSEcCtD
Bismuth Subsalicylate—Rash—Prednisolone—ulcerative colitis	7.49e-05	0.00145	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Prednisolone—ulcerative colitis	7.49e-05	0.00145	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methylprednisolone—ulcerative colitis	7.46e-05	0.00145	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisolone—ulcerative colitis	7.45e-05	0.00144	CcSEcCtD
Bismuth Subsalicylate—Constipation—Prednisone—ulcerative colitis	7.39e-05	0.00143	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Hydrocortisone—ulcerative colitis	7.38e-05	0.00143	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	7.36e-05	0.0027	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—ulcerative colitis	7.33e-05	0.00269	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Hydrocortisone—ulcerative colitis	7.32e-05	0.00142	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Hydrocortisone—ulcerative colitis	7.31e-05	0.00142	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	7.3e-05	0.00268	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—CRP—ulcerative colitis	7.28e-05	0.00267	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Hydrocortisone—ulcerative colitis	7.27e-05	0.00141	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Triamcinolone—ulcerative colitis	7.23e-05	0.0014	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methylprednisolone—ulcerative colitis	7.21e-05	0.0014	CcSEcCtD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	7.16e-05	0.00263	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	7.14e-05	0.00262	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Prednisone—ulcerative colitis	7.12e-05	0.00138	CcSEcCtD
Bismuth Subsalicylate—Nausea—Prednisolone—ulcerative colitis	7.06e-05	0.00137	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Dexamethasone—ulcerative colitis	7.02e-05	0.00136	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Betamethasone—ulcerative colitis	7.02e-05	0.00136	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	6.99e-05	0.00257	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	6.98e-05	0.00256	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Triamcinolone—ulcerative colitis	6.95e-05	0.00135	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methylprednisolone—ulcerative colitis	6.93e-05	0.00134	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	6.9e-05	0.00253	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Hydrocortisone—ulcerative colitis	6.9e-05	0.00134	CcSEcCtD
Bismuth Subsalicylate—Rash—Triamcinolone—ulcerative colitis	6.89e-05	0.00133	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Triamcinolone—ulcerative colitis	6.89e-05	0.00133	CcSEcCtD
Bismuth Subsalicylate—Rash—Methylprednisolone—ulcerative colitis	6.88e-05	0.00133	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methylprednisolone—ulcerative colitis	6.87e-05	0.00133	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Prednisone—ulcerative colitis	6.86e-05	0.00133	CcSEcCtD
Bismuth Subsalicylate—Headache—Triamcinolone—ulcerative colitis	6.85e-05	0.00133	CcSEcCtD
Bismuth Subsalicylate—Headache—Methylprednisolone—ulcerative colitis	6.83e-05	0.00132	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Prednisone—ulcerative colitis	6.83e-05	0.00132	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Betamethasone—ulcerative colitis	6.79e-05	0.00131	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Dexamethasone—ulcerative colitis	6.79e-05	0.00131	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—ICAM1—ulcerative colitis	6.69e-05	0.00246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	6.57e-05	0.00241	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Betamethasone—ulcerative colitis	6.56e-05	0.00127	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Dexamethasone—ulcerative colitis	6.56e-05	0.00127	CcSEcCtD
Bismuth Subsalicylate—Nausea—Triamcinolone—ulcerative colitis	6.49e-05	0.00126	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methylprednisolone—ulcerative colitis	6.48e-05	0.00125	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Betamethasone—ulcerative colitis	6.31e-05	0.00122	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Dexamethasone—ulcerative colitis	6.31e-05	0.00122	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	6.29e-05	0.00231	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	6.27e-05	0.0023	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	6.25e-05	0.0023	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Dexamethasone—ulcerative colitis	6.25e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Rash—Betamethasone—ulcerative colitis	6.25e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Dexamethasone—ulcerative colitis	6.25e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Betamethasone—ulcerative colitis	6.25e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Headache—Dexamethasone—ulcerative colitis	6.21e-05	0.0012	CcSEcCtD
Bismuth Subsalicylate—Headache—Betamethasone—ulcerative colitis	6.21e-05	0.0012	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	6.21e-05	0.00228	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	6.17e-05	0.00227	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Prednisone—ulcerative colitis	6.11e-05	0.00118	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	6.03e-05	0.00222	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ALB—ulcerative colitis	6e-05	0.0022	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	5.96e-05	0.00219	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Prednisone—ulcerative colitis	5.91e-05	0.00114	CcSEcCtD
Bismuth Subsalicylate—Nausea—Betamethasone—ulcerative colitis	5.89e-05	0.00114	CcSEcCtD
Bismuth Subsalicylate—Nausea—Dexamethasone—ulcerative colitis	5.89e-05	0.00114	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	5.78e-05	0.00212	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Prednisone—ulcerative colitis	5.71e-05	0.00111	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	5.61e-05	0.00206	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	5.58e-05	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—JAK2—ulcerative colitis	5.58e-05	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Prednisone—ulcerative colitis	5.49e-05	0.00106	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	5.48e-05	0.00201	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Prednisone—ulcerative colitis	5.45e-05	0.00105	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Prednisone—ulcerative colitis	5.44e-05	0.00105	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	5.43e-05	0.002	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	5.42e-05	0.00199	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Prednisone—ulcerative colitis	5.41e-05	0.00105	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	5.31e-05	0.00195	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	5.24e-05	0.00192	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	5.2e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.19e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	5.19e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	5.17e-05	0.0019	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Prednisone—ulcerative colitis	5.13e-05	0.000994	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—IFNG—ulcerative colitis	5.09e-05	0.00187	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	5.08e-05	0.00187	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—RELA—ulcerative colitis	5.02e-05	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	5.01e-05	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	5e-05	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	4.93e-05	0.00181	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IL2—ulcerative colitis	4.87e-05	0.00179	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	4.71e-05	0.00173	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL1B—ulcerative colitis	4.54e-05	0.00167	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL2—ulcerative colitis	4.52e-05	0.00166	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.46e-05	0.00164	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	4.36e-05	0.0016	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—NFKB1—ulcerative colitis	4.23e-05	0.00156	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.22e-05	0.00155	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.22e-05	0.00155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.16e-05	0.00153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	4.07e-05	0.0015	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	4.05e-05	0.00149	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	4.04e-05	0.00149	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	3.99e-05	0.00147	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	3.95e-05	0.00145	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	3.88e-05	0.00142	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—ulcerative colitis	3.8e-05	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CHP1—ulcerative colitis	3.78e-05	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	3.67e-05	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	3.61e-05	0.00132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CHP1—ulcerative colitis	3.58e-05	0.00131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	3.52e-05	0.00129	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	3.51e-05	0.00129	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	3.36e-05	0.00124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	3.32e-05	0.00122	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—ulcerative colitis	3.29e-05	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	3.29e-05	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	3.27e-05	0.0012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—DLD—ulcerative colitis	3.26e-05	0.0012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	3.23e-05	0.00119	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GNA12—ulcerative colitis	3.23e-05	0.00119	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGAL—ulcerative colitis	3.17e-05	0.00116	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—ulcerative colitis	3.12e-05	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—ulcerative colitis	3.02e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CHP1—ulcerative colitis	3e-05	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—ulcerative colitis	2.9e-05	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	2.88e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SEL1L—ulcerative colitis	2.84e-05	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.81e-05	0.00103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	2.74e-05	0.00101	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—ulcerative colitis	2.66e-05	0.000976	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.63e-05	0.000966	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	2.62e-05	0.000961	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	2.61e-05	0.000959	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—DLD—ulcerative colitis	2.59e-05	0.00095	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	2.56e-05	0.00094	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LTF—ulcerative colitis	2.55e-05	0.000937	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CHP1—ulcerative colitis	2.42e-05	0.000891	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.27e-05	0.000835	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	2.25e-05	0.000828	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CALM3—ulcerative colitis	2.25e-05	0.000825	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.24e-05	0.000822	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	2.11e-05	0.000776	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—DLD—ulcerative colitis	2.09e-05	0.000769	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	2.06e-05	0.000758	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	1.97e-05	0.000724	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.86e-05	0.000684	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC11A1—ulcerative colitis	1.82e-05	0.000667	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.74e-05	0.000639	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.72e-05	0.000633	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.72e-05	0.000632	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAML2—ulcerative colitis	1.63e-05	0.0006	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.55e-05	0.000569	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.53e-05	0.000563	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.51e-05	0.000556	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—ulcerative colitis	1.44e-05	0.00053	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CALM3—ulcerative colitis	1.42e-05	0.000521	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.41e-05	0.000518	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.37e-05	0.000503	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.36e-05	0.000498	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CALM3—ulcerative colitis	1.34e-05	0.000494	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.34e-05	0.000493	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTGS1—ulcerative colitis	1.25e-05	0.000459	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.23e-05	0.000452	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CALM3—ulcerative colitis	1.13e-05	0.000414	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.11e-05	0.000407	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCB1—ulcerative colitis	1.1e-05	0.000405	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ADCY5—ulcerative colitis	1.03e-05	0.000378	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—JAK2—ulcerative colitis	1.02e-05	0.000373	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS1—ulcerative colitis	1.01e-05	0.000372	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ADCY5—ulcerative colitis	9.75e-06	0.000358	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CALM3—ulcerative colitis	9.11e-06	0.000335	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—ulcerative colitis	8.86e-06	0.000326	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCB1—ulcerative colitis	8.76e-06	0.000322	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.71e-06	0.00032	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ADCY5—ulcerative colitis	8.17e-06	0.0003	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—ulcerative colitis	7.67e-06	0.000282	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCB1—ulcerative colitis	7.09e-06	0.00026	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—ulcerative colitis	6.91e-06	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—ulcerative colitis	6.9e-06	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADCY5—ulcerative colitis	6.61e-06	0.000243	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—ulcerative colitis	6.09e-06	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JAK2—ulcerative colitis	6.08e-06	0.000223	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—ulcerative colitis	6.04e-06	0.000222	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD4—ulcerative colitis	5.77e-06	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—ulcerative colitis	5.69e-06	0.000209	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—ulcerative colitis	5.48e-06	0.000201	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—ulcerative colitis	4.93e-06	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT3—ulcerative colitis	4.46e-06	0.000164	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—ulcerative colitis	4.14e-06	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—ulcerative colitis	3.88e-06	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—ulcerative colitis	3.12e-06	0.000115	CbGpPWpGaD
